Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Revolutionizing Insulin Delivery: Smart Implants for Continuous Monitoring and Release
*Corresponding Author:Received Date: May 01, 2024 / Published Date: May 30, 2024
Copyright: © 0 . This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Insulin therapy is fundamental in managing diabetes mellitus, yet traditional delivery methods present challenges such as dosing inaccuracies, adherence issues, and risk of hypoglycemia. Smart implantable devices offer a promising solution by providing continuous monitoring of blood glucose levels and on-demand insulin release. This
article explores the emerging field of smart implants for insulin delivery, highlighting technological advancements, clinical implications, and future directions. Miniaturized devices equipped with glucose sensors and insulin actuators enable precise control of blood glucose levels while minimizing patient burden. Closed-loop systems integrate
continuous glucose monitoring with automated insulin delivery algorithms, offering real-time adjustments based on glucose levels. Biocompatible materials ensure long-term functionality and safety of smart implants. Clinical benefits include improved glycemic control, enhanced patient satisfaction, and prevention of long-term complications. Future
research should focus on long-term safety and efficacy studies, integration with artificial intelligence, and improving accessibility and affordability. Smart implants have the potential to revolutionize insulin therapy and improve outcomes for individuals living with diabetes.
